CRD007

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
113	筋ジストロフィー	2

113. 筋ジストロフィー

臨床試験数 : 646 / 薬物数 : 471 - (DrugBank : 105) / 標的遺伝子数 : 59 - 標的パスウェイ数 : 170

trials per page:

Showing 1 to 2 of 2 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01540604 (ClinicalTrials.gov)	February 2012	23/2/2012	CRD007for the Treatment of Duchenne Muscular Dystrophy, Becker Muscular Dystrophy and Symptomatic Ca ...	An Open-label, Un-controlled, Single-centre Trial Investigating the Efficacy and Safety of CRD007in ...	Duchenne Muscular Dystrophy;Becker Muscular Dystrophy	Drug: CRD007	Cardoz AB	NULL	Completed	2 Years	11 Years	Both		Phase 2	Sweden
2	EUCTR2011-004667-76-SE (EUCTR)	19/12/2011	21/10/2011	An open single center study investigating the effects and side-effects of CRD007in children with Duc ...	An open-label, un-controlled, single-centre trial investigating the efficacy and safety of CRD007tab ...	Duchenne Muscular Dystrophy (DMD), Becker Muscular Dystrophy (BMD) and symptomatic carriers for DMD ...	Product Name: pemirolast Product Code: CRD007 INN or Proposed INN: PEMIROLAST	Cardoz AB	NULL	Not Recruiting			Female: yes Male: yes			Sweden

First Previous1Next Last